首页> 外国专利> Genetic and protein therapy products for treating cystic fibrosis and inducing aglutathione-s-transferase function

Genetic and protein therapy products for treating cystic fibrosis and inducing aglutathione-s-transferase function

机译:用于治疗囊性纤维化和诱导谷胱甘肽-s-转移酶功能的遗传和蛋白质治疗产品

摘要

The invention concerns a DNA molecule containing a DNA sequence whereof the expression product has a common peptide sequence with part of that of CFTR, in particular the one extending from the 430th to the 660th residue of the latter and having a glutathione carrier function. Said DNA molecule is useful for constructing vectors useful in gene therapy for treating cystic fibrosis.
机译:本发明涉及一种DNA分子,该DNA分子包含其表达产物具有与CFTR的一部分相同的肽序列的DNA序列,特别是从CFTR的430th至660th残基延伸并具有CFTR的DNA序列。谷胱甘肽载体功能。所述DNA分子可用于构建可用于治疗囊性纤维化的基因治疗的载体。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号